Could oxime HI-6 really be considered as "broad-spectrum" antidote?

Journal of Applied Biomedicine

Volumn 7, Issue 3, 2009, Pages 143-149

  Kuča, Kamil ^a,b   Musílek, Kamil ^b   Jun, Daniel ^a,b,c   Pohanka, Miroslav ^a   Karasová, Jana Žd'árová ^b   Novotný, Ladislav ^a   Musilová, Lucie ^d  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

^d Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Acetylcholinesterase; Broad spectrum; HI 6; Nerve agent; Oxime; Pesticide; Reactivator

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; CHLORPYRIFOS; CHLORPYRIFOS METHYL; CHOLINESTERASE REACTIVATOR; CYCLOSARIN; DICHLORVOS; PARAOXON; SARIN; SOMAN; TABUN;

ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; ENZYME REACTIVATION; IN VITRO STUDY; NONHUMAN; RAT;

EID: 70349198596     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.32725/jab.2009.016     Document Type: Article

References (47)

1. Bajgar J, Fusek J, Kuča K, Bartošová L, Jun D: Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction. Mini Rev Med Chem 7:461-466, 2007.
2. Bartošová L, Kuča K, Kunešová G, Jun D: The acute toxicity of acetylcholinesterase reactivators in mice in relation to their structure. Neurotox Res 9:291-296, 2006.
3. Bond GR, Pieche S, Sonicki Z, Gamaluddin H, El Guindi M, Sakr M, El Seddawy A, Abouzaid M, Youssef A: Pediatric Insecticide Study Group. A clinical decision aid for triage of children younger than 5 years and with organophosphate or carbamate insecticide exposure in developing countries. Ann Emerg Med 52:617-622, 2008.
4. Chennamaneni SR, Vobalaboina V, Garlapati A: Quaternary salts of 4,3′ and 4,4′bis-pyridinium monooximes: Synthesis and biological activity. Bioorg Med Chem Lett 15:3076-3080, 2005.
5. Gyenge M, Kalasz H, Petroianu G, Laufer R, Kuča K, Tekes K: Measurement of K-27, an oxime-type cholinesterase reactivator by high performance liquid chromatography with electrochemical detection from different biological samples. J Chromatogr A 1161:146-151, 2007.
6. Hamilton MG, Lundy PM: HI-6 therapy of soman and tabun poisoning in primates and rodents. Arch Toxicol 63:144-149, 1989.
7. Jun D, Stodůlka P, Kuča K, Kolečkář V, Doležal B, Šimon P, Veverka M: HPLC analysis of HI-6 dichloride and dimethanesulfonate - antidotes against nerve agents and organophosphorus pesticides. Anal Lett 40:2783-2787, 2007.
8. Jun D, Stodůlka P, Kuča K, Kolečkář V, Doležal B, Šimon P, Veverka M: TLC analysis of intermediates arising during the preparation of oxime HI-6 dimethanesulfonate. J Chromatogr Sci 46:316-319, 2008.
9. Kassa J, Kuča K, Cabal J, Paar M: A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vitro and in vivo methods. J Toxicol Environ Health 69:1875-1882, 2006.
10. Kassa J, Kuča K, Bartošová L, Kunešová G: The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr Org Chem 11:267-283, 2007a.
11. Kassa J, Jun D, Kuča K, Bajgar J: A comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats. Basic Clin Pharmacol Toxicol 101:328-332, 2007b.
12. Kim TH, Kuča K, Jun D, Jung YS: Design and synthesis of new bis-pyridinium oximes as cyclosarin-inhibited acetylcholinesterase reactivators. Bioorg Med Chem Lett 15:2914-2917, 2005.
13. Kim TH, Oh KA, Park NJ, Lim YJ, Yum EK, Jung YS: Reactivation study of pyridinium oximes for acetylcholinesterases inhibited by paraoxon or DFP. J Appl Biomed 4:67-72, 2006.
14. Kuča K, Cabal J, Kassa J: In vitro reactivation of sarin-inhibited brain acetylcholinesterase from various species by various oximes. J Enzyme Inhib Med Chem 20:227-232, 2005.
15. Kuča K, Cabal J: Evaluation of newly synthesized reactivators of the brain cholinesterase inhibited by sarin-nerve agent. Toxicol Mech Methods 15:247-252, 2005.
16. Kuča K, Kassa J: In vitro reactivation of acetylcholinesterase using of the oxime K027. Vet Hum Toxicol 46:15-18, 2004a.
17. Kuča K, Kassa J: Oximes-induced reactivation of rat brain acetylcholinesterase inhibited by VX agent. Hum Exp Toxicol 23:167-171, 2004b.
18. Kuča K, Cabal J, Kassa J, Jun D, Hrabinová M: In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase. J Toxicol Environ Health A 69:1431-1440, 2006.
19. Kuča K, Musílek K, Stodůlka P, Marek J, Hanušová P, Jun D, Hrabinová M, Kassa J, Doležal B: Twelve different HI-6 salts and their potency to reactivate cyclosarin inhibited AChE in vitro. Lett Drug Des Discov 4:510-512, 2007.
20. Kuča K, Stodůlka P, Hrabinová M, Hanušová P, Jun D, Doležal B: Convenient preparation of the oxime HI-6 (dichloride and DMS) - antidote against nerve agents. Def Sci J 58:399-404, 2008.
21. Lorke DE, Hasan MY, Nurulain SM, Sheen R, Kuča K, Petroianu GA: Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the brain: comparison with obidoxime. J Appl Toxicol 27:482-490, 2007.
22. Lorke DE, Nurulain SM, Hasan MY, Kuča K, Musílek K, Petroianu GA: Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: In vivo efficacy to protect from diisopropylfluorophosphate (DFP) toxicity. J Appl Toxicol 28:920-928, 2008a.
23. Lorke DE, Hasan MY, Arafat K, Kuča K, Musílek K, Schmitt A, Petroianu GA: In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate. J Appl Toxicol 28:422-429, 2008b.
24. Lorke DE, Hasan MY, Nurulain SM, Kuča K, Schmitt A, Petroianu GA: Efficacy of two new asymmetric bispyridinium oximes (K-27 and K - 48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6. Toxicol Mech Methods 19:327-333, 2009.
25. Musílek K, Holas O, Hambálek J, Kuča K, Jun D, Dohnal V, Doležal M: Synthesis of bispyridinium compounds bearing propane linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetyl-cholinesterase. Lett Org Chem 3:831-835, 2006a.
26. Musílek K, Lipka L, Račáková V, Kuča K, Jun D, Dohnal V, Doležal V: New methods in synthesis of acetylcholinesterase reactivators and evaluation of their potency to reactivate cyclosarin-inhibited AChE. Chem Pap 60:48-51, 2006b.
27. Musílek K, Jun D, Cabal J, Kassa J, Gunn-Moore F, Kuča K: Design of a Potent Reactivator of Tabun-Inhibited Acetylcholinesterase - Synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4- (4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203), J Med Chem 50:5514-5518, 2007a.
28. Musílek K, Kuča K, Jun D, Doležal M: Progress in synthesis of new acetylcholinesterase reactivators during the period 1990-2004. Curr Org Chem 11:229-238, 2007b.
29. Novotný L, Karasová J, Kuča K, Bajgar J, Misík J: Influence of different wals of euthanasisa on the aktivity of cholinesterases in the rat. J Appl Biomed 7:133-136, 2009.
30. Nurulain SM, Lorke DE, Hasan MY, Shafiullah M, Kuča K, Musílek K, Petroianu GA: Efficacy of eight experimental bispyridinium oximes against paraoxon-induced mortality: comparison with the conventional oximes pralidoxime and obidoxime. Neurotox Res 16:60-67, 2009.
31. 2 linkers between pyridinium rings and their reactivity against VX. Bioorg Med Chem Lett 16:4852-4855, 2006.
32. Oh KA, Park NJ, Park NS, Kuča K, Jun D, Jung YS: Determination of reactivation potency for DFP-and paraoxon-Inhibited acetylcholinesterases by pyridinium oximes. Chem Biol Interact 175:365-367, 2008.
33. Ohta H, Ohmori T, Suzuki S, Ikegaya H, Sakurada K, Takatori T: New safe method for preparation of sarin-exposed human erythrocytes acetylcholinesterase using non-toxic and stable sarin analogue isopropyl p-nitrophenyl methylphosphonate and its application to evaluation of nerve agent antidotes. Pharm Res 23:2827-2833, 2006.
34. Petroianu GA, Arafat K, Kuča K, Kassa J: Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibitied by paraoxon. J Appl Toxicol 26:64-71, 2006a.
35. Petroianu GA, Nurulain SM, Nagelkerke N, Al-Sultan MAH, Kuča K, Kassa J: Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. J Appl Toxicol 26:262-268, 2006b.
36. Petroianu GA, Hasan MY, Nurulain SM, Nagelkerke N, Kassa J, Kuča K: New K-oximes (K-27 and K-48) in comparison with obidoxime (LuH-6), HI-6, trimedoxime (TMB-4) and pralidoxime (2-PAM): survival in rats exposed ip to the organophosphate paraoxon. Toxicol Mech Methods 17:401-408, 2007a.
37. Petroianu GA, Nurulain SM, Nagelkerke N, Shafiullah M, Kassa J, Kuca K: Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon. J Appl Toxicol 27:453-457, 2007b.
38. Petroianu GA, Arafat K, Nurulain SM, Kuča K, Kassa J: In vitro oxime reactivation of red blood cell acetylcholinesterase inhibitied by methyl-paraoxon. J Appl Toxicol 27:168-175, 2007c.
39. Pícha J, Kuča K, Kivala M, Kohout M, Cabal J, Liška F: New group of monoquaternary reactivators of the acetylcholinesterase inhibited by nerve agents. J Enzyme Inhib Med Chem 20:233-237, 2005.
40. Pohanka M, Jun D, Kuča K: Amperometric biosensor for evaluation of competitive cholinesterase inhibition by the reactivator HI-6. Anal Lett 40:2351-2359, 2007.
41. Singh H, Moorad-Doctor D, Ratcliffe RH, Wachtel K, Castillo A, Garcia GE: A rapid cation-exchange HPLC method for detection and quantification of pyridinium oximes in plasma and tissue. J Anal Toxicol 31:69-74, 2007.
42. Tekes K, Hasan MY, Sheen R, Kuča K, Petroianu G, Ludanyi K, Kalasz H: HPLC determination of the serum concentration of K-27, a novel oxime-type cholinesterase reactivator. J Chromatogr A 1122:84-87, 2006.
43. Thiermann H, Szinicz L, Eyer F, Worek F, Eyer P, Felgenhauer N, Zilker T: Modern strategies in therapy of organophosphate poisoning. Toxicol Lett 107:233-239, 1999.
44. Tu AT: Overview of sarin terrorist attacks in Japan. ACS Symp Ser Am Chem Soc 745:304-317, 2000.
45. Wiesner J, Kříž Z, Kuča K, Jun D, Koča J: Acetylcholinesterases - the structural similarities and differences. J Enzyme Inhib Med Chem 22:417-424, 2007.
46. 2 linker and their reactivation potency for organophosphorus agents - inhibited acetylcholinesterase. Bioorg Med Chem 15:7704-7710, 2007.
47. Žd'árová Karasová J, Bajgar J, Novotný L, Kuča K: Is a high dose of Huperzine A really suitable for pretreatment against high doses of soman? J Appl Biomed 7:93-99, 2009.